Adapting The Adpkd Outcomes Model to Predict Cost Consequence In Italian Patients With Autosomal Dominant Polycystic Kidney Disease (Adpkd) Treated With Jinarc (Tolvaptan)
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2930
https://www.valueinhealthjournal.com/article/S1098-3015(15)05011-1/fulltext
Title :
Adapting The Adpkd Outcomes Model to Predict Cost Consequence In Italian Patients With Autosomal Dominant Polycystic Kidney Disease (Adpkd) Treated With Jinarc (Tolvaptan)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)05011-1&doi=10.1016/j.jval.2015.09.2930
First page :
A755
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
2333